Bulygina, V.
224  results:
Search for persons X
?
3

P.0578 Chemogenetic activation of glutamatergic neurons in ..:

Dygalo, N. ; Drozd, U.S. ; Bulygina, V.V....
European Neuropsychopharmacology.  53 (2021)  - p. S424 , 2021
 
?
4

P.0418 Neonatal dexamethasone prevents an increase of pro-i..:

Kalinina, T. ; Sukhareva, E. ; Bulygina, V...
European Neuropsychopharmacology.  53 (2021)  - p. S303-S304 , 2021
 
?
5

P.087 The relationship between the noradrenergic system act..:

Kalinina, T. ; Bulygina, V. ; Egorova, K...
European Neuropsychopharmacology.  40 (2020)  - p. S55-S56 , 2020
 
?
6

P.216 Long-term up-regulation of tyrosine hydroxylase gene ..:

Kalinina, T. ; Sukhareva, E. ; Bulygina, V....
European Neuropsychopharmacology.  29 (2019)  - p. S166-S167 , 2019
 
?
7

P.425 Extrahypothalamic CRH and its receptors change tyrosi..:

Sukhareva, E.V. ; Lanshakov, D. ; Kalinina, T...
European Neuropsychopharmacology.  29 (2019)  - p. S301-S302 , 2019
 
?
 
?
10

P.111 Subanesthetic dose of ketamine relieves depression-li..:

Dygalo, N. ; Drozd, U.S. ; Kalinina, T.S....
European Neuropsychopharmacology.  29 (2019)  - p. S94 , 2019
 
?
11

Ketamine improves depressive symptoms caused by stress and ..:

Dygalo, N. ; Drozd, U.S. ; Kalinina, T.S....
European Neuropsychopharmacology.  29 (2019)  - p. S212 , 2019
 
?
13

Dexamethasone upregulates levels of proapoptotic proteins p..:

Bulygina, V. ; Kalinina, T.S. ; Lanshakov, D.A..
European Neuropsychopharmacology.  27 (2017)  - p. S609-S610 , 2017
 
?
 
?
 
1-15